Top Markets
Coin of the day
Beijing Biostar Pharms Co Ltd Beijing Biostar Pharms Co Ltd

Beijing Biostar Pharms Co Ltd

2563
Rank in Stocks #21402
Beijing Biostar Pharmaceuticals Co. Ltd. primarily focuses on developing... Beijing Biostar Pharmaceuticals Co. Ltd. primarily focuses on developing innovative therapies for tumors. The company is dedicated to creating novel anti-cancer drugs, each secured by independent intellectual property rights. A prominent product in its portfolio is the Utidelone injection, a next-generation microtubule inhibitor produced through a unique microbial fermentation process. This enterprise was co-founded by Li Tang and Rong Guo Qiu on July 11, 2002, and operates from its headquarters in Beijing, China.
Share Price
$0.44774181
Last synced: 2026-08-21
Market Cap
$108.23M
Change (1 day)
2.19%
Change (1 year)
-61.12%
Country
CN
Trade Beijing Biostar Pharms Co Ltd (2563)

Category

Operating Margin for Beijing Biostar Pharms Co Ltd (2563)
Operating Margin as of 2026 TTM: 0.00%
According to Beijing Biostar Pharms Co Ltd latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Beijing Biostar Pharms Co Ltd from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
-149.01% -
US
25.72% -
AU
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.